[1] SIEGEL R L, MILLER K D, FUCHS H E, et al. Cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72(1):7-33. doi:  10.3322/caac.21708
[2] YANG T, XIONG Y L, ZENG Y F, et al. Current status of immunotherapy for non-small cell lung cancer[J]. Front Pharmacol, 2022, 13:989461. doi:  10.3389/fphar.2022.989461
[3] WANG K, YU B X, PATHAK J L. An update in clinical utilization of photodynamic therapy for lung cancer[J]. J Cancer, 2021, 12(4):1154-1160. doi:  10.7150/jca.51537
[4] EL-HUSSEIN A, MANOTO S L, OMBINDA-LEMBOUMBA S, et al. A review of chemotherapy and photodynamic therapy for lung cancer treatment[J]. Anticancer Agents Med Chem, 2021, 21(2):149-161.
[5] KWIATKOWSKI S, KNAP B, PRZYSTUPSKI D, et al. Photodynamic therapy–mechanisms, photosensitizers and combinations[J]. Biomed Pharmacother, 2018, 106:1098-1107. doi:  10.1016/j.biopha.2018.07.049
[6] BASKARAN R, LEE J, YANG S G. Clinical development of photodynamic agents and therapeutic applications[J]. Biomater Res, 2018, 22:25. doi:  10.1186/s40824-018-0140-z
[7] AZIZ B, AZIZ I, KHURSHID A, et al. An overview of potential natural photosensitizers in cancer photodynamic therapy[J]. Biomedicines, 2023, 11(1):224. doi:  10.3390/biomedicines11010224
[8] MATHAI S, SMITH T A, GHIGGINO K P. Singlet oxygen quantum yields of potential porphyrin-based photosensitisers for photodynamic therapy[J]. Photochem Photobiol Sci, 2007, 6(9):995-1002. doi:  10.1039/b705853e
[9] CORREIA J H, RODRIGUES J A, PIMENTA S, et al. Photodynamic therapy review: principles, photosensitizers, applications, and future directions[J]. Pharmaceutics, 2021, 13(9):1332. doi:  10.3390/pharmaceutics13091332
[10] GUNAYDIN G, GEDIK M E, AYAN S. Photodynamic therapy for the treatment and diagnosis of cancer-a review of the current clinical status[J]. Front Chem, 2021, 9:686303. doi:  10.3389/fchem.2021.686303